The Medicines & Healthcare Products Regulatory Agency (MHRA) will simultaneously launch a consultation, Public Consultation (MLX 336) : Patient Group Directions, on proposals for changes to the legislation governing the supply and/or administration of pain relief through morphine and diamorphine by nurses and pharmacists working under Patient Group Directions.